Advertisement

Topics

BMS boosts I/O pipeline with IFM acquisition

05:34 EDT 4 Aug 2017 | BioPharmaDive

Bristol-Myers Squibb is buying its way into another immuno-oncology approach as it tries to maintain a leadership position. 

Original Article: BMS boosts I/O pipeline with IFM acquisition

NEXT ARTICLE

More From BioPortfolio on "BMS boosts I/O pipeline with IFM acquisition"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...